Katarzyna Kempinska

Title(s)Postdoctoral Scholar, Neurosciences
SchoolHealth Sciences
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Anderson AM, Nguyen ML, Potter M, Rosario D, Kempinska K, Ellis RJ, Diccianni M, Letendre SL. Comparison of bead array and glass nanoreactor multi-analyte platforms for the evaluation of CNS and peripheral inflammatory markers during HIV infection. J Immunol Methods. 2019 Feb; 465:7-12. PMID: 30468733.
      View in: PubMed
    2. Borkin D, Klossowski S, Pollock J, Miao H, Linhares BM, Kempinska K, Jin Z, Purohit T, Wen B, He M, Sun D, Cierpicki T, Grembecka J. Complexity of Blocking Bivalent Protein-Protein Interactions: Development of a Highly Potent Inhibitor of the Menin-Mixed-Lineage Leukemia Interaction. J Med Chem. 2018 Jun 14; 61(11):4832-4850. PMID: 29738674.
      View in: PubMed
    3. Kempinska K, Malik B, Borkin D, Klossowski S, Shukla S, Miao H, Wang J, Cierpicki T, Grembecka J. Pharmacologic Inhibition of the Menin-MLL Interaction Leads to Transcriptional Repression of PEG10 and Blocks Hepatocellular Carcinoma. Mol Cancer Ther. 2018 01; 17(1):26-38. PMID: 29142068.
      View in: PubMed
    4. Kicielinska J, Szczygiel A, Rossowska J, Anger N, Kempinska K, Switalska M, Kaszowska M, Wietrzyk J, Boratynski J, Pajtasz-Piasecka E. Oral Administration of Polymyxin B Modulates the Activity of Lipooligosaccharide E. coli B against Lung Metastases in Murine Tumor Models. PLoS One. 2016; 11(2):e0148156. PMID: 26829479; PMCID: PMC4735115.
    5. Borkin D, Pollock J, Kempinska K, Purohit T, Li X, Wen B, Zhao T, Miao H, Shukla S, He M, Sun D, Cierpicki T, Grembecka J. Property Focused Structure-Based Optimization of Small Molecule Inhibitors of the Protein-Protein Interaction between Menin and Mixed Lineage Leukemia (MLL). J Med Chem. 2016 Feb 11; 59(3):892-913. PMID: 26744767.
      View in: PubMed
    6. He S, Malik B, Borkin D, Miao H, Shukla S, Kempinska K, Purohit T, Wang J, Chen L, Parkin B, Malek SN, Danet-Desnoyers G, Muntean AG, Cierpicki T, Grembecka J. Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent manner. Leukemia. 2016 Feb; 30(2):508-13. PMID: 26084867; PMCID: PMC4830728.
    7. Borkin D, He S, Miao H, Kempinska K, Pollock J, Chase J, Purohit T, Malik B, Zhao T, Wang J, Wen B, Zong H, Jones M, Danet-Desnoyers G, Guzman ML, Talpaz M, Bixby DL, Sun D, Hess JL, Muntean AG, Maillard I, Cierpicki T, Grembecka J. Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell. 2015 Apr 13; 27(4):589-602. PMID: 25817203; PMCID: PMC4415852.
    8. Goszczynski TM, Filip-Psurska B, Kempinska K, Wietrzyk J, Boratynski J. Hydroxyethyl starch as an effective methotrexate carrier in anticancer therapy. Pharmacol Res Perspect. 2014 Jun; 2(3):e00047. PMID: 25505592; PMCID: PMC4186415.
    9. Gubernator J, Lipka D, Korycinska M, Kempinska K, Milczarek M, Wietrzyk J, Hrynyk R, Barnert S, Süss R, Kozubek A. Efficient human breast cancer xenograft regression after a single treatment with a novel liposomal formulation of epirubicin prepared using the EDTA ion gradient method. PLoS One. 2014; 9(3):e91487. PMID: 24621591; PMCID: PMC3951386.
    10. Boryczka S, Bebenek E, Wietrzyk J, Kempinska K, Jastrzebska M, Kusz J, Nowak M. Synthesis, structure and cytotoxic activity of new acetylenic derivatives of betulin. Molecules. 2013 Apr 17; 18(4):4526-43. PMID: 23595090.
      View in: PubMed
    11. Tubek B, Mitula P, Niezgoda N, Kempinska K, Wietrzyk J, Wawrzenczyk C. Synthesis and cytotoxic activity of new betulin and betulinic acid esters with conjugated linoleic acid (CLA). Nat Prod Commun. 2013 Apr; 8(4):435-8. PMID: 23738445.
      View in: PubMed